Report cover image

Global Oral OTC Analgesics Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 187 Pages
SKU # APRC20553021

Description

Summary

According to APO Research, The global Oral OTC Analgesics market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Oral OTC Analgesics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Oral OTC Analgesics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Oral OTC Analgesics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Oral OTC Analgesics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Oral OTC Analgesics include Takeda Pharmaceutical Company, Sun Pharmaceutical Industries, Sanofi, Johnson & Johnson, Novartis, Pfizer, GlaxoSmithKline, Bayer and Reckitt Benckiser, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Oral OTC Analgesics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Oral OTC Analgesics, also provides the sales of main regions and countries. Of the upcoming market potential for Oral OTC Analgesics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oral OTC Analgesics sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Oral OTC Analgesics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Oral OTC Analgesics sales, projected growth trends, production technology, application and end-user industry.

Oral OTC Analgesics Segment by Company

Takeda Pharmaceutical Company
Sun Pharmaceutical Industries
Sanofi
Johnson & Johnson
Novartis
Pfizer
GlaxoSmithKline
Bayer
Reckitt Benckiser
Oral OTC Analgesics Segment by Type

Acetaminophen (TYLENOL)
Salicylates
Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Oral OTC Analgesics Segment by Application

Online Pharmacies
Hospital Pharmacies
Retail Pharmacies
Oral OTC Analgesics Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral OTC Analgesics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral OTC Analgesics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral OTC Analgesics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oral OTC Analgesics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral OTC Analgesics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oral OTC Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Oral OTC Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

187 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Oral OTC Analgesics Market Size, 2020 VS 2024 VS 2031
1.3 Global Oral OTC Analgesics Market Size Estimates and Forecasts (2020-2031)
1.4 Global Oral OTC Analgesics Sales Estimates and Forecasts (2020-2031)
1.5 Global Oral OTC Analgesics Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Oral OTC Analgesics Market Dynamics
2.1 Oral OTC Analgesics Industry Trends
2.2 Oral OTC Analgesics Industry Drivers
2.3 Oral OTC Analgesics Industry Opportunities and Challenges
2.4 Oral OTC Analgesics Industry Restraints
3 Oral OTC Analgesics Market by Manufacturers
3.1 Global Oral OTC Analgesics Revenue by Manufacturers (2020-2025)
3.2 Global Oral OTC Analgesics Sales by Manufacturers (2020-2025)
3.3 Global Oral OTC Analgesics Average Sales Price by Manufacturers (2020-2025)
3.4 Global Oral OTC Analgesics Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Oral OTC Analgesics Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Oral OTC Analgesics Manufacturers, Product Type & Application
3.7 Global Oral OTC Analgesics Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Oral OTC Analgesics Market CR5 and HHI
3.8.2 Global Top 5 and 10 Oral OTC Analgesics Players Market Share by Revenue in 2024
3.8.3 2024 Oral OTC Analgesics Tier 1, Tier 2, and Tier 3
4 Oral OTC Analgesics Market by Type
4.1 Oral OTC Analgesics Type Introduction
4.1.1 Acetaminophen (TYLENOL)
4.1.2 Salicylates
4.1.3 Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
4.2 Global Oral OTC Analgesics Sales by Type
4.2.1 Global Oral OTC Analgesics Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Oral OTC Analgesics Sales by Type (2020-2031)
4.2.3 Global Oral OTC Analgesics Sales Market Share by Type (2020-2031)
4.3 Global Oral OTC Analgesics Revenue by Type
4.3.1 Global Oral OTC Analgesics Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Oral OTC Analgesics Revenue by Type (2020-2031)
4.3.3 Global Oral OTC Analgesics Revenue Market Share by Type (2020-2031)
5 Oral OTC Analgesics Market by Application
5.1 Oral OTC Analgesics Application Introduction
5.1.1 Online Pharmacies
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.2 Global Oral OTC Analgesics Sales by Application
5.2.1 Global Oral OTC Analgesics Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Oral OTC Analgesics Sales by Application (2020-2031)
5.2.3 Global Oral OTC Analgesics Sales Market Share by Application (2020-2031)
5.3 Global Oral OTC Analgesics Revenue by Application
5.3.1 Global Oral OTC Analgesics Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Oral OTC Analgesics Revenue by Application (2020-2031)
5.3.3 Global Oral OTC Analgesics Revenue Market Share by Application (2020-2031)
6 Global Oral OTC Analgesics Sales by Region
6.1 Global Oral OTC Analgesics Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Oral OTC Analgesics Sales by Region (2020-2031)
6.2.1 Global Oral OTC Analgesics Sales by Region (2020-2025)
6.2.2 Global Oral OTC Analgesics Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Oral OTC Analgesics Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Oral OTC Analgesics Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Oral OTC Analgesics Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Oral OTC Analgesics Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Oral OTC Analgesics Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Oral OTC Analgesics Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Oral OTC Analgesics Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Oral OTC Analgesics Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Oral OTC Analgesics Revenue by Region
7.1 Global Oral OTC Analgesics Revenue by Region
7.1.1 Global Oral OTC Analgesics Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Oral OTC Analgesics Revenue by Region (2020-2025)
7.1.3 Global Oral OTC Analgesics Revenue by Region (2026-2031)
7.1.4 Global Oral OTC Analgesics Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Oral OTC Analgesics Revenue (2020-2031)
7.2.2 North America Oral OTC Analgesics Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Oral OTC Analgesics Revenue (2020-2031)
7.3.2 Europe Oral OTC Analgesics Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Oral OTC Analgesics Revenue (2020-2031)
7.4.2 Asia-Pacific Oral OTC Analgesics Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Oral OTC Analgesics Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Oral OTC Analgesics Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Takeda Pharmaceutical Company
8.1.1 Takeda Pharmaceutical Company Comapny Information
8.1.2 Takeda Pharmaceutical Company Business Overview
8.1.3 Takeda Pharmaceutical Company Oral OTC Analgesics Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Takeda Pharmaceutical Company Oral OTC Analgesics Product Portfolio
8.1.5 Takeda Pharmaceutical Company Recent Developments
8.2 Sun Pharmaceutical Industries
8.2.1 Sun Pharmaceutical Industries Comapny Information
8.2.2 Sun Pharmaceutical Industries Business Overview
8.2.3 Sun Pharmaceutical Industries Oral OTC Analgesics Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Sun Pharmaceutical Industries Oral OTC Analgesics Product Portfolio
8.2.5 Sun Pharmaceutical Industries Recent Developments
8.3 Sanofi
8.3.1 Sanofi Comapny Information
8.3.2 Sanofi Business Overview
8.3.3 Sanofi Oral OTC Analgesics Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Sanofi Oral OTC Analgesics Product Portfolio
8.3.5 Sanofi Recent Developments
8.4 Johnson & Johnson
8.4.1 Johnson & Johnson Comapny Information
8.4.2 Johnson & Johnson Business Overview
8.4.3 Johnson & Johnson Oral OTC Analgesics Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Johnson & Johnson Oral OTC Analgesics Product Portfolio
8.4.5 Johnson & Johnson Recent Developments
8.5 Novartis
8.5.1 Novartis Comapny Information
8.5.2 Novartis Business Overview
8.5.3 Novartis Oral OTC Analgesics Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Novartis Oral OTC Analgesics Product Portfolio
8.5.5 Novartis Recent Developments
8.6 Pfizer
8.6.1 Pfizer Comapny Information
8.6.2 Pfizer Business Overview
8.6.3 Pfizer Oral OTC Analgesics Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Pfizer Oral OTC Analgesics Product Portfolio
8.6.5 Pfizer Recent Developments
8.7 GlaxoSmithKline
8.7.1 GlaxoSmithKline Comapny Information
8.7.2 GlaxoSmithKline Business Overview
8.7.3 GlaxoSmithKline Oral OTC Analgesics Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 GlaxoSmithKline Oral OTC Analgesics Product Portfolio
8.7.5 GlaxoSmithKline Recent Developments
8.8 Bayer
8.8.1 Bayer Comapny Information
8.8.2 Bayer Business Overview
8.8.3 Bayer Oral OTC Analgesics Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Bayer Oral OTC Analgesics Product Portfolio
8.8.5 Bayer Recent Developments
8.9 Reckitt Benckiser
8.9.1 Reckitt Benckiser Comapny Information
8.9.2 Reckitt Benckiser Business Overview
8.9.3 Reckitt Benckiser Oral OTC Analgesics Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Reckitt Benckiser Oral OTC Analgesics Product Portfolio
8.9.5 Reckitt Benckiser Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Oral OTC Analgesics Value Chain Analysis
9.1.1 Oral OTC Analgesics Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Oral OTC Analgesics Production Mode & Process
9.2 Oral OTC Analgesics Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Oral OTC Analgesics Distributors
9.2.3 Oral OTC Analgesics Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.